CYP2A6 gene
Evidence from:
primary |
all sources
Related entities (72)
Mentioned in (17)
Papers in which this entity is mentioned.
- Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. (2022)
- Genetics of substance use disorders in the era of big data. (2021)
- Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions. (2021)
- Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
- CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. (2019)
- Human Genetics of Addiction: New Insights and Future Directions. (2018)
- A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism. (2015)
- Identification of CHRNA5 rare variants in African-American heavy smokers. (2014)
- The co-occurring use and misuse of cannabis and tobacco: a review. (2012)
- The genetic basis of addictive disorders. (2012)
- Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. (2012)
- Assessing the impact of nicotine dependence genes on the risk of facial clefts: An example of the use of national registry and biobank data. (2012)
- Uncovering hidden variance: pair-wise SNP analysis accounts for additional variance in nicotine dependence. (2011)
- Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. (2011)
- Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease. (2009)
- Genome-wide and candidate gene association study of cigarette smoking behaviors. (2009)
- Rate of nicotine metabolism and withdrawal symptoms in adolescent light smokers. (2008)
Merged raw entities (21)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cyp2a6 | gene | 16 | 61 |
| cyp2a6 variants | variant | 3 | 3 |
| cyp2a | gene | 2 | 7 |
| cyp2a6*12 | variant | 2 | 9 |
| cyp2a6*2 | variant | 2 | 10 |
| cyp2a6*4 | variant | 2 | 6 |
| cyp2a6*9 | variant | 2 | 8 |
| -48t>g | gene | — | — |
| cyp2a6*2 variant | gene | — | — |
| cyp2a6 enzyme | gene | — | — |
| cyp2a6 gene variants | gene | — | — |
| cyp2a subfamily | gene | — | — |
| cytochrome p450 2a6 | gene | — | — |
| cytochrome p450 family 2 subfamily a member 6 | gene | — | — |
| cytochrome p450 family 2 subfamily a polypeptide 6 | gene | — | — |
| human cyp2a6 | gene | — | — |
| l160h | gene | — | — |
| null activity allele | gene | — | — |
| rs1801272 | gene | — | — |
| rs28399433 | gene | — | — |
| whole gene deletion | gene | — | — |